Metraipolis › archive › dc_ce10fa63a7e6
Real-World Dupilumab in Type 2 Chronic Obstructive Pulmonary Disease (COPD): A Single-Centre Compassionate-Use Case Series — Europe PMC PMID:42511891
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42511891
- DOI
- 10.3390/biomedicines14071416
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T05:18:13.958Z
- SHA-256 of the archived text
a9231eb99b828838e2a147c36403ba7e417c69e03cb3e1ca361d96a018bbb015- Stable URL of this page
https://metraipolis.com/documento/dc_ce10fa63a7e6
How to cite
Real-World Dupilumab in Type 2 Chronic Obstructive Pulmonary Disease (COPD): A Single-Centre Compassionate-Use Case Series — Europe PMC PMID:42511891 — Europe PMC (en), https://europepmc.org/article/MED/42511891 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce10fa63a7e6 (Metraipolis archive dc_ce10fa63a7e6, sha256 a9231eb99b828838e2a147c36403ba7e417c69e03cb3e1ca361d96a018bbb015)
BibTeX
@misc{dcce10fa63a7e6,
title = {Real-World Dupilumab in Type 2 Chronic Obstructive Pulmonary Disease (COPD): A Single-Centre Compassionate-Use Case Series — Europe PMC PMID:42511891},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42511891},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce10fa63a7e6; sha256 a9231eb99b828838e2a147c36403ba7e417c69e03cb3e1ca361d96a018bbb015},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42511891. Agents can read the archived copy with the MCP tool read_document.